Overview

Noroxin Efficacy and Safety Trial

Status:
Unknown status
Trial end date:
2018-07-30
Target enrollment:
Participant gender:
Summary
To determine the efficacy and safety of Norfloxacin (Noroxin)
Phase:
Phase 4
Details
Lead Sponsor:
OBS Pakistan
Treatments:
Norfloxacin